✦ LIBER ✦

Safety and tolerability of active immunotherapy cad106 in two phase ii studies in Alzheimer's patients

✍ Scribed by Orgogozo, Jean-Marc; Andreasen, Niels; Farlow, Martin; Winblad, Bengt; Graf, Ana; Moreau, Jessie; Caputo, Angelika; Collober, Carole

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term administration of active immun

✍ Ana Graf; Niels Andreasen; Martin Farlow; Marie-Emmanuelle Riviere; Peter Quarg; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 146 KB

Safety, tolerability, and antibody respo

✍ Bengt Winblad; Niels Andreasen; Lennart Minthon; Annette Floesser; Georges Imber 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 606 KB

Results of the first-in-man study with t

✍ Bengt G. Winblad; L. Minthon; A. Floesser; G. Imbert; T. Dumortier; Y. He; P. Ma 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 61 KB

S2-04-06: Safety, tolerability and immun

✍ Bengt Winblad 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Safety and tolerability of BMS-708163 in

✍ Salloway, Stephen; Coric, Vlad; Brody, Mark; Andreasen, Niels; van Dyck, Christo 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 82 KB

Safety and Tolerability of Tegaserod in

✍ Quigley, Eamonn M.M.; Wald, Arnold; Fidelholtz, James; Boivin, Michel; Pecher, E 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 397 KB